These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 15173005

  • 1. Complex regulation of signal transducers and activators of transcription 3 activation in normal and malignant keratinocytes.
    Quadros MR, Peruzzi F, Kari C, Rodeck U.
    Cancer Res; 2004 Jun 01; 64(11):3934-9. PubMed ID: 15173005
    [Abstract] [Full Text] [Related]

  • 2. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
    Zhang T, Ma J, Cao X.
    Biochem J; 2003 Dec 01; 376(Pt 2):457-64. PubMed ID: 14498832
    [Abstract] [Full Text] [Related]

  • 3. Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor.
    Shao H, Cheng HY, Cook RG, Tweardy DJ.
    Cancer Res; 2003 Jul 15; 63(14):3923-30. PubMed ID: 12873986
    [Abstract] [Full Text] [Related]

  • 4. STAT 3 activation in head and neck squamous cell carcinomas is controlled by the EGFR.
    Hambek M, Baghi M, Strebhardt K, May A, Adunka O, Gstöttner W, Knecht R.
    Anticancer Res; 2004 Jul 15; 24(6):3881-6. PubMed ID: 15736426
    [Abstract] [Full Text] [Related]

  • 5. STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo.
    Kijima T, Niwa H, Steinman RA, Drenning SD, Gooding WE, Wentzel AL, Xi S, Grandis JR.
    Cell Growth Differ; 2002 Aug 15; 13(8):355-62. PubMed ID: 12193474
    [Abstract] [Full Text] [Related]

  • 6. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
    Cohen EE, Lingen MW, Zhu B, Zhu H, Straza MW, Pierce C, Martin LE, Rosner MR.
    Cancer Res; 2006 Jun 15; 66(12):6296-303. PubMed ID: 16778206
    [Abstract] [Full Text] [Related]

  • 7. STAT3 activation accompanies keratinocyte differentiation.
    Hauser PJ, Agrawal D, Hackney J, Pledger WJ.
    Cell Growth Differ; 1998 Oct 15; 9(10):847-55. PubMed ID: 9790496
    [Abstract] [Full Text] [Related]

  • 8. Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation.
    Sano S, Chan KS, Kira M, Kataoka K, Takagi S, Tarutani M, Itami S, Kiguchi K, Yokoi M, Sugasawa K, Mori T, Hanaoka F, Takeda J, DiGiovanni J.
    Cancer Res; 2005 Jul 01; 65(13):5720-9. PubMed ID: 15994947
    [Abstract] [Full Text] [Related]

  • 9. The nonsteroidal anti-inflammatory drug sulindac causes down-regulation of signal transducer and activator of transcription 3 in human oral squamous cell carcinoma cells.
    Nikitakis NG, Hamburger AW, Sauk JJ.
    Cancer Res; 2002 Feb 15; 62(4):1004-7. PubMed ID: 11861373
    [Abstract] [Full Text] [Related]

  • 10. STAT signaling in head and neck cancer.
    Song JI, Grandis JR.
    Oncogene; 2000 May 15; 19(21):2489-95. PubMed ID: 10851047
    [Abstract] [Full Text] [Related]

  • 11. Epidermal growth factor receptor--mediated stat3 signaling blocks apoptosis in head and neck cancer.
    Rubin Grandis J, Zeng Q, Drenning SD.
    Laryngoscope; 2000 May 15; 110(5 Pt 1):868-74. PubMed ID: 10807365
    [Abstract] [Full Text] [Related]

  • 12. Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells.
    Lin J, Jin X, Rothman K, Lin HJ, Tang H, Burke W.
    Cancer Res; 2002 Jan 15; 62(2):376-80. PubMed ID: 11809683
    [Abstract] [Full Text] [Related]

  • 13. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.
    Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214
    [Abstract] [Full Text] [Related]

  • 14. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.
    Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, Muro-Cacho C, Livingston S, Karras J, Pow-Sang J, Jove R.
    Cancer Res; 2002 Nov 15; 62(22):6659-66. PubMed ID: 12438264
    [Abstract] [Full Text] [Related]

  • 15. Thyroid hormone promotes the phosphorylation of STAT3 and potentiates the action of epidermal growth factor in cultured cells.
    Lin HY, Shih A, Davis FB, Davis PJ.
    Biochem J; 1999 Mar 01; 338 ( Pt 2)(Pt 2):427-32. PubMed ID: 10024519
    [Abstract] [Full Text] [Related]

  • 16. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells.
    Nishimoto A, Yu Y, Lu Z, Mao X, Ren Z, Watowich SS, Mills GB, Liao WS, Chen X, Bast RC, Luo RZ.
    Cancer Res; 2005 Aug 01; 65(15):6701-10. PubMed ID: 16061651
    [Abstract] [Full Text] [Related]

  • 17. Expression of epidermal growth factor receptor and related phosphorylation proteins in hypertrophic scars and normal skin.
    Cheng B, Fu X, Sun T, Sun X, Sheng Z.
    Chin Med J (Engl); 2002 Oct 01; 115(10):1525-8. PubMed ID: 12490102
    [Abstract] [Full Text] [Related]

  • 18. EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas.
    Xu K, Shu HK.
    Cancer Res; 2007 Jul 01; 67(13):6121-9. PubMed ID: 17616668
    [Abstract] [Full Text] [Related]

  • 19. Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma.
    Squarize CH, Castilho RM, Sriuranpong V, Pinto DS, Gutkind JS.
    Neoplasia; 2006 Sep 01; 8(9):733-46. PubMed ID: 16984731
    [Abstract] [Full Text] [Related]

  • 20. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.
    Masuda M, Suzui M, Yasumatu R, Nakashima T, Kuratomi Y, Azuma K, Tomita K, Komiyama S, Weinstein IB.
    Cancer Res; 2002 Jun 15; 62(12):3351-5. PubMed ID: 12067972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.